Anúncio
Anúncio
EWTX
Edgewise Therapeutics, Inc. Common Stock
24.64
USDPatrocinado
+1.70
+7.43%
07 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
24.59
-0.05
-0.22%
Relatórios de Lucros EWTX
Rácio de surpresa positiva
EWTX separação 13 de 19 últimas estimativas.
68%
Próximo Relatório
Data do Próximo Relatório
02 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.44
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+12.82%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/+4.76%
Edgewise Therapeutics, Inc. Common Stock earnings per share and revenue
On 06 de nov. de 2025, EWTX reported earnings of -0.39 USD per share (EPS) for Q3 25, beating the estimate of -0.40 USD, resulting in a 3.82% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.61% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analistas forecast an EPS of -0.44 USD, with revenue projected to reach -- USD, implying an aumentar of 12.82% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Edgewise Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Edgewise Therapeutics, Inc. Common Stock reported EPS of -$0.39, beating estimates by 3.82%, and revenue of $0.00, 0% as expectations.
How did the market react to Edgewise Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -1.61%, changed from $17.37 before the earnings release to $17.09 the day after.
When is Edgewise Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 02 de mar. de 2026.
What are the forecasts for Edgewise Therapeutics, Inc. Common Stock's next earnings report?
Based on 14
analistas, Edgewise Therapeutics, Inc. Common Stock is expected to report EPS of -$0.44 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio